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ABSTRACT
	 Through an examination of personal narratives, we sought to elucidate the experiences of people 
receiving chronic opioid therapy for chronic non-cancer pain. The participants were 34 adult volunteer 
outpatients treated in pain clinics. Data were collected using semi-structured interviews and analyzed using 
the grounded theory approach. The participants described their daily life experiences of chronic pain and 
opioid therapy. Informed consent and ethical approval were obtained. Six categories were extracted: “Barriers 
to living with chronic pain,” “Facing injustice or extreme chronic pain and catastrophizing,” “Making an 
attempt to improve one’s condition,” “Ambivalence about medical treatment,” “Finding a compromise while 
living with chronic pain,” and “Regaining a life.” These findings expand our understanding of Japanese 
patients with chronic non-cancer pain who receive opioid treatment and how they cope in their daily lives. 
(Accepted November 3, 2019)
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1.　Background
 Approximately 45.2% of Japanese adults have chronic 
pain. However, 50% of these individuals discontinue 
treatment despite persistence of pain because of 
dissatisfaction with treatment 1）. Many Japanese adults 
with chronic musculoskeletal pain lose or change their 
occupation, leave college, or miss work 2）. Chronic pain 
can cause physical disability, depression, lower quality of 
life (QoL), and financial and employment difficulties 3-6）. 
The findings of the inaugural “Meeting on Chronic 
Pain” 7） were used to propose measures for improving 
QoL of such patients. Subsequently, a comprehensive 
program incorporating many social aspects, including 
the evaluation of activities of daily living (ADL) and QoL, 
as well as patient education, was implemented 2, 3, 8）. 
However, there have been fewer Japanese nursing 
studies focusing on chronic non-cancer pain than on 
chronic cancer-related pain. At least one study 9） found 
that Japanese nurses often handle chronic pain incorrectly. 
 Opioids have been widely used for the management 
of acute, chronic, cancer, and non-cancer pain worldwide 10）. 
However, the efficacy of opioid analgesics for patients 
with chronic non-cancer pain is unclear 11-13）. Previous 
studies 11, 14） have reported that opioid therapy is useful for 
alleviating chronic pain symptoms, improving QoL, and 
reducing treatment costs. Consequently, opioid prescriptions 
for chronic pain have increased dramatically 15, 16）. In older 
adults with chronic pain and no significant comorbidity, 
short-term opioid use is associated with a reduction in 
pain intensity and better physical functioning 17, 18）. 
However, this trend has been accompanied by greatly 
increased levels of prescription opioid overdose, abuse, 
addiction, and diversion 19-21）. In addition, there is 
insufficient evidence to validate the effectiveness of 
long-term opioid therapy for chronic pain improvement 22）. 
In Japan, opioid therapies are mostly restricted to 
patients with cancer pain, and opioid drugs available to 
patients with chronic non-cancer pain are limited to codeine 
phosphate, morphine hydrochloride, fentanyl, buprenorphine, 
pentazocine, and tramadol 23）. These factors have 
limited the widespread use of opioid therapy. 
Regarding the literature, fewer Japanese studies have 
focused on chronic non-cancer than cancer-related pain, 
and there have been almost no reports on Japanese 
patients with chronic non-cancer pain receiving opioid 
therapy.
 To date, research on chronic non-cancer pain has 
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focused on quantitative aspects measured using 
objective tools based on numeric, verbal, and visual 
analog scales (VAS). Although these are useful in 
objectively quantifying pain, they do not reflect the 
multidimensional experience of life for outpatients with 
chronic non-cancer pain receiving opioid therapy. Also, 
little qualitative research 24, 25） has been conducted on 
patients' perspectives of chronic non-cancer pain, 
especially those receiving opioid therapy 26-28）. 
Narratives, or meaning-making reconstructions of life 
events, are an important source of qualitative 
information 29）.
 Through an examination of personal narratives 
using a grounded theory approach, we sought to elucidate 
the experiences of individuals receiving opioid therapy 
for chronic non-cancer pain.
2.　Methods
2・1　Design
 The grounded theory approach of simultaneous 
data collection and constant comparative analysis was 
implemented. The purpose of this qualitative study was to 
examine the lived experiences of adults receiving opioid 
therapy for relief of chronic non-cancer pain through the 
examination of data obtained through serial recorded 
narrative interviews. The lead author, a registered nurse 
and public health nurse with qualitative research 
experience in the field of chronic pain in Japan, conducted 
each interview one on one.
2・2　Patients
 The study cohort consisted of individuals who 
used opioid analgesic prescriptions for non-cancer pain. 
The specific inclusion criteria were as follows: adults 
aged 20 years and older who were receiving strong or 
weak opioid therapy at a pain clinic and whose chronic 
pain had continued for at least six months. Individuals 
diagnosed with dementia were excluded. 
 Participants were recruited from pain clinics in 
two hospitals in Sapporo. Data were collected between 
March 2014 and January 2015 at one hospital and 
between February 2015 and April 2016 at the other. 
The lead author visited the outpatient department of 
both hospitals and requested the appropriate specialist 
to identify the relevant patients, who were then briefly 
interviewed to determine eligibility and interest. 
Participants were recruited at the respective clinics 
while awaiting treatment in the outpatient ward. 
 Owing to the limited number of persons able and 
willing to verbalize their experiences, theoretical 
sampling was achieved by collecting further data about 
emerging categories during interviews instead of seeking 
participants with specific experiences. Interviews were 
conducted until data saturation was achieved. As a 
result, we conducted 34 patient interviews. Two 
participants had a cooling off period of three and four 
months, respectively.
2・3　Data Collection
 In-depth serial interviews, conducted in the privacy 
of the participant's home or other agreed-upon location, 
were audio recorded. The first interview was conducted 
in a private space in the hospital while the second was 
held at either the participant's home or the hospital. 
 Participants were interviewed two times. The first 
interview, semi-structured using an interview guide, 
consisted of six open questions: “What happened to cause 
your pain?” “What problems have you encountered?” 
“How do you manage your pain?” “What is the worst 
part of having chronic pain or what has changed 
because of it?” “What is it like to be taking long-term 
opioids for chronic non-cancer pain?” and “What do 
you hope for the future?” This interview guide was 
based on previous qualitative research on chronic non-
cancer pain treated with opioid therapy 26-28）. During 
the second interview, the participants validated the 
content of the first interview and the meanings of 
statements were clarified. The interviews, which lasted 
1–2.5 h, were audio recorded and transcribed verbatim.
 Medical history was obtained using a structured 
interview. The following variables were recorded: age, 
sex, occupation, pain location, duration of continuous pain, 
and duration of opioid therapy. Current pain status 
severity was assessed using a VAS consisting of a 10 
centimeter horizontal line, with start and end points 
labeled “no pain” and “worst possible pain,” respectively 30）. 
To evaluate pain intensity and interference with QoL 
during the last month, the self-reported Japanese 
version of the Short Form 36 version 2 (SF36v2) was 
used. The SF36v2 is a commonly used measure with 
considerable evidence supporting its reliability and 
validity across samples and languages 31）.
2・4　Data Analysis
 We used a modified grounded theory approach to 
code and analyze transcripts 32）. First, we read and 
completed field notes on interview transcripts and 
discussed emerging thematic topics. Then, we combined 
76 final deductive codes, based on broad topics from the 
semi-structured interview guide, with inductive codes 
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(i.e., those that emerged from the interview content 
and subsequent analytic discussions and field notes). 
After repeated independent iteration of transcript 
coding and group discussion, we developed distinct 
codebooks for patient interviews. Two leading pain and 
palliative care nursing researchers versed in qualitative 
data analysis and two pain clinic specialists recurrently 
examined the data in parts and in their entirety to 
verify inter-rater reliability of the coding scheme. We 
resolved coding discrepancies through consensus.
2・5　Rigor
 Methods to enhance the standards of rigor, credibility, 
and fittingness were utilized 33, 34）. Credibility was 
established by conducting participant interviews at 
two points. After the initial interview, records were 
transcribed, and an initial analysis of the transcript 
was made. The second interview was used to validate 
the codes with the participant as well as to achieve 
clarity. Credibility was also established through the 
careful use of a literature review 35）. The initial literature 
review was conducted to confirm the existence of a gap 
in the literature. After data collection and analysis, a 
literature review employing comparative analysis with 
existing research was conducted. This twofold method 
was used to limit the influence of the literature on 
category construction. Fittingness, or the transferability of 
findings, was confirmed by the comparative analysis, 
with the goal of illustrating parallels with existing 
research regarding the use of opioid therapy for chronic 
non-cancer pain 32）. 
2・6　Ethical Considerations 
 Ethical clearance was obtained from the university 
and the industry partner hospital ethics committees. 
Anonymity and confidentially were assured. All 
participants were given a plain language statement 
and an opportunity to ask questions about the study. 
Pseudonyms and codes were allocated for all data 
including field notes and identifying information was 
stored separately. Written informed consent was 
obtained prior to each interview.
3.　Results
 We conducted 34 outpatient interviews (Table 1). 
Fifty-two percent of the patients were elderly and 50% 
Table 1. Participants' Characteristics (N = 34)
Characteristic n (%)
Age (years) 22-40 3 (8.8)
41-64 13 (38.3)
65-74 12 (35.3)
75+ 6 (17.6)
Sex Women 17 (50.0)
Men 17 (50.0)
Pain duration, years, mean ± SD 11.3± 9.6
Opioid therapy, years, mean ± SD 3.5± 2.8
Current pain status (VAS), mean ± SD 4.0 ± 2.6
Opioid therapy
(multiple other)
Morphine, oral 12 (35.3)
Fentanyl, transdermal 5 (14.7)
Buprenorphine, transdermal 2 (5.9)
Tramadol hydrochloride, oral 4 (11.8)
Tramadol hydrochloride/acetaminophen, oral 14 (41.2)
Codeine, oral 2 (5.9)
Pain location Head pain/trigeminal neuralgia 5 (14.7)
Breast/back neuralgia 6 (17.6)
Lower-back pain 8 (23.5)
Interstitial cystitis/phallus pain 5 (14.7)
Extremity complex regional pain syndrome 10 (29.4)
SF36v2
(maximum score, 100 points)
Physical functioning 58.7± 30.2
Physical role functioning 58.5± 33.2
Body pain 36.7± 21.0
General health perception 47.2 ± 27.7
Vitality 44.7± 21.8
Social functioning 51.8 ± 37.6
Emotional role functioning 66.9 ± 31.9
Mental health 56.9 ± 25.9
Note. SD = standard deviation, VAS = visual analog scale, SF36v2 = Short Form 36 version 2.
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were women. The mean durations of chronic pain and 
opioid administration were 11.3 ± 9.6 years and 3.5 ± 2.8 
years, respectively. The mean current pain status (VAS) 
score was 4.0 ± 2.6. All participants reported SF36v2 
scores that were lower than the Japanese average 36）. 
 Six categories reflecting participants' experiences 
of opioid therapy were extracted (Figure 1): “Barriers 
to living with chronic pain,” “Facing injustice or extreme 
chronic pain and catastrophizing,” “Making an attempt to 
improve one's condition,” “Ambivalence about medical 
treatment,” “Finding a compromise while living with 
chronic pain,” and “Regaining a life.”
3・1　Barriers to Living with Chronic Pain
 Participants reported stigma and two types of 
barriers. 
 Lack of societal understanding of chronic pain. 
Several knowledge barriers about pain treatment were 
noted, such as lack of knowledge regarding pain clinics, 
pain treatment, and neuropathic pain, and difficulty 
understanding the concept of prescriptions: “I think 
others cannot understand why I go to the department of 
anesthesiology. Still others do not understand what a 
pain clinic is for. I said I was going there to reduce pain. 
Others said, what is anesthesiology?” (7-540)
 Concerned family and friends often interfered, and 
participants had trouble explaining their pain because 
of social incomprehension. Therefore, they kept it a 
secret: “Even physicians will not understand my pain 
because they have none.” (1-752) “I'm just not saying I 
had my hurt leg. I keep it secret. Because I fear that I 
will lose a chance to go back to my job.” (2-303-305)
 Barriers to chronic opioid therapy. Participants 
frequently experienced negativity, stigma, bias, and disdain 
because they were undergoing chronic opioid therapy: 
“I can't throw away garbage because I don't want my 
Figure 1. Six categories and their associations regarding the living with chronic non-cancer pain while receiving opioid therapy in Japan.
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neighbors to see the patches and think I am a drug addict!” 
(12-2355- 2357) 
 Participants often spoke of the barriers to obtaining 
their medications from pharmacists and medical 
professionals: “Morphine is not easily available” (7-
1468) and “If I change pharmacies suddenly, they may 
not have an available stock, and I would have to make 
another visit. How tiring!” (7-565)
3・2　 Facing Injustice or Extreme Chronic Pain and 
Catastrophizing
 Participants engaged in catastrophizing and 
experienced feelings of injustice while living with 
chronic pain.
 Experiencing intense pain attacks. Many patients 
described living with uncertain, intense, and serious 
pain attacks: “I'm scared because of the suddenness 
and severity of pain.” (3-164)
 Debilitating chronic pain caused by daily life. 
Chronic pain was influenced by one's surroundings 
(i.e., temperature, weather, stress, outside stimuli). The 
pain varied in intensity but participants were constantly 
aware of it: “I live with my parents now. Surprisingly, I 
am now stressed, which has worsened my pain.” (7-188)
 Inability to function in daily life. Participants lost 
their ability to adapt to situations and reported difficulties 
in the emotional, physical, and role domains. 
 Emotional. Loss or abandonment of hope, religion, 
vitality, and ability to effectively function on an emotional 
level (e.g., emotional imbalance, fear of increased pain, 
exhaustion associated with posttraumatic stress disorder, 
hesitation to try new things) was common: “Every time 
I saw traffic accidents on TV, I felt sick and impatient 
and my heart rate increased, and I ended up thinking 
about the person who caused my accident.” (1-877-883)
 Physical . Problems in physical functioning were 
common. The loss of the ability to perform self-care 
necessitated hospitalization in some cases: “I can't sleep 
or eat when the pain comes; this condition has continued 
for a long time.” (3-258)
 Role.  Inability to perform role functions in social 
and work relationships was common: “For example, 
when I attend social gatherings and party, it is very bad, 
because I need my pain drugs. When someone asks me, 
‘Do you have a health problem?' I always say, ‘It's okay.' 
I'm lying, always. I am considering not attending such 
events anymore.” (7-250)
 Enduring injustice and humiliation. For most 
participants, the onset of chronic pain involved injustice or 
uncertain outcomes, and a struggle with this injustice: 
“I had a goal that I was working toward, but one drunk 
person ruined my life in an instant.” (1-889) 
 Participants received various long-term treatments 
for pain relief, and the nature of the pain changed over 
time. They allowed repeated work-ups, attempted last-
resort treatments, and seized every opportunity for 
pain relief: “Perhaps I should not have been operated on, 
but I allowed it because I wanted to be free of sudden 
pain…All in all, my treatment involved abdominal and 
visceral nerve blocks.” (5-147) 
 Catastrophizing. Catastrophizing was defined as 
the abandonment of any hope for the future and lack of 
concern for life due to sensitivity to surroundings or 
chronic pain. Lack of concern for life consisted of the 
innermost desire to terminate pain, with or without a 
suicide plan, attempt, or hoping for an accident: “I 
cannot overcome my pain. I honestly hope to be run over 
by a truck so that I am not responsible for my death.” 
(10-1406)
3・3　Making an Attempt to Improve One's Condition
 Participants had made many attempts to improve 
their condition. 
 Utilizing social services for pain disorders. Some 
participants had received welfare and social security 
services because of their pain disorder and family 
problems. One participant spoke of his utilization of 
social welfare to meet the requirements of day-to-day 
life, because he was hemiplegic and had serious pain 
attacks at times: “My home was entirely renovated for 
my care, but it was still hard to live there. It so 
happened that a nursing home was built right in front 
of my house. I moved there because of the free rooms, 
accessible bathrooms, nursing staff, and care and 
cleaning. My wife would visit every so often, but I am so 
damaged that I'm better left alone.” (3-311)
 Self-care. Participants spoke about self-care in daily 
life to improve their condition, in terms of functioning, 
pain, and health: “I could walk a long distance. But, I 
thought that I could not go home by myself, if I had 
pain increase; so, I went back home on the way. I had 
strolled in the cold winter… If I thought I was tired, I 
may go home on the way. When I feel well, I will walk 
around the park…I always do.” (13-2099) 
 In addition, they spoke about trying to understand 
their medicine: “I thought that patients should study 
medicine. Though the pharmacist can give me details 
about my medication, I can learn better from people's 
58 Yukari Shindo et al.
experiences. In this age of the internet, I can collect 
information from anywhere.” (7-2079)
 Continuous pain relief efforts. Participants were 
unable to stop thinking about curing the pain, and tried 
new methods:
 “I know that it is lingering pain, but I hope it goes 
away. I believe it will. I'm not giving up. Not at all. I'd 
like it to be 0 (VAS).” (6-2333)
3・4　Ambivalence About Medical Treatment
 Ambivalence about receiving opioid therapy and 
medical treatment involved a thankful attitude regarding 
the benefits of treatment as well as negativity because 
of the associated experiences. 
 Reliance on, and reserve toward, medical treatment. 
Participants underwent various long-term treatments 
for pain relief. They experienced dependence on medical 
treatment and trust in medical specialists. At the same 
time, they hesitated to ask their physician about treatment: 
“I am reliant on medicines even though they do not provide 
complete relief; I don't know what would happen if I 
didn't take them. My fear is of the pain.” (6-2423) “I 
hope my prescription has been changed from morphine 
powder to pills, but I can't ask my doctor, which is 
distressing.” (5-1069-71)
 Apprehension about medical dependence. Having 
taken various medicines for pain relief, participants 
experienced drug tolerance and became doubtful about 
treatment. They considered a reduction in drug use 
because of their health: “I would like to avoid drugs, 
but the pain is too much to bear. I really dislike taking 
medication orally.” (6-2439) 
 Improvement through opioid therapy. Participants 
reported that opioid therapy improved QoL and pain 
levels. In addition, participants thought they were lucky 
that they did not experience serious side effects: “My 
joints and fractured body are sore and throbbing, but I 
think the pills have been effective. So, if I took the 
medicine after I received an epidural block, I could 
ease…So, I can sleep since then.” (1-667)
 Understanding expressed by surrounding people. 
Participants frequently stated that only people close to 
them, such as family, friends, and medical professionals, 
understood the need for opioid therapy for chronic non-
cancer pain. A participant who was in a work accident 
that caused neuroparalysis in the lower half of his body 
with chronic pain said the following: “My wife said she 
wasn't worried because I was taking prescribed 
medication. She understood that the medication was 
for a very serious condition but was also clear about the 
fact that it was necessary for pain relief.” (3-985)
 Final therapy for pain. Some participants referred 
to opioid therapy as a last resort: “I could not be cured 
and tried various medications. So, I finally took 
morphine.” (2-482)
 Frustrated and discouraged by opioid therapy. 
Participants often experienced frustration with opioid 
therapy. The strong side effects interfered with their 
daily lives, and their pain increased if medication was 
interrupted. They also talked about opioid overdoses 
failing to bring relief: “At first, I thought morphine 
didn't have an effect, but when I stopped drinking it, 
the pain spread everywhere” (1-657-63) “I took two doses 
of the drug when my pain got to 100 (VAS). I was going 
to work, and because one does had not worked, I took 
the second. But when I took two doses, I had vomited. 
My physician scolded me for having taken an extra 
dose. ” (5-460-464)
 Some participants felt discouraged by the failure 
of opioid therapy. A nurse receiving opioid therapy from 
a pain physician said: “I have two type pains, which 
from osteoarthritis of the knee and internal pain, and 
morphine has had no effect osteoarthritis pain.” (5-889)
 One participant who went through withdrawal 
symptoms due to medication interruption stated: 
“When I started opioid therapy, my doctor said, ‘You 
will be given a drug and patient narcotic management 
numbers. Please make up your mind.'  At that time, I 
gave consent easily because I had so much pain. When 
I think of it now, I regret having agreed…But the 
quantity of morphine was so little, I thought it would be 
OK to drink it thrice a day. I regretted it a little.” (7-996-
1214)
 Minor damage caused by opioid therapy. 
Participants frequently experienced minor side effects 
and damage in daily life because of opioid treatment 
such as constipation, erectile dysfunction, nausea, and 
economic problems, and received care for side effects: “I 
had no sexual desire. This was surely because of morphine 
treatment.” (10-2675-77) “I tried taking a fentanyl patch 
last year in the hospital. I had increased the quantity 
from 1 mg to 3 mg (2 mg + 1 mg), but I abandoned it 
because of the large amount of money required. The 
buprenorphine tape is relatively cheap, so, I take that 
now.” (21-666)
 Fear of the impact of opioids. There was dread related 
to the impact of opioid treatment. Some participants were 
careful about revealing details surrounding their chronic 
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opioid therapy because of the fear of prejudice: “Though 
I can talk about having pain, morphine is a bit of a 
taboo. Out of the fear of not being able to return to work, 
I never told anyone about taking morphine.” (2-337)
 In addition, patients feared drug withdrawal symptoms 
and serious side effects of chronic opioid therapy. One 
patient aged over 75 switched from a strong opioid 
(morphine) to a weak opioid (codeine) because he had 
serious side effects from receiving long opioid therapy: 
“I became a senile old man, those days. No mistake. I 
did strange things and couldn't pick up food with 
chopsticks. I realized there was a problem, so my daughter 
found a neurology hospital I could visit. The physician 
there told me to stop taking morphine. Although I initially 
told him my pain clinic doctor was in charge, I eventually 
backed the new doctor's decision and switched to 
codeine. The pain was gone in about a week. Yes, I 
could recover from dementia.” (13-2119, 2980)
 A patient with trigeminal neuralgia who received 
a gasserian ganglion block and who had withdrawal 
symptoms because of stopping morphine by herself 
recounted her experience: “…And because it gave me 
peace of mind and relief (when I had serious pain attacks), 
I had taken morphine for nearly a decade. However, I 
regretted having resorted to drugs.” (7-823) “The symptoms 
that still remain are drug dependent. In other words, 
my mental withdrawal symptoms are more difficult to 
manage than the physical pain. I'm afraid of taking 
opioid drugs; so, I thought this drug is remaining.” (7-
2089-2111)
3・5　 Finding a Compromise While Living with Chronic 
Pain 
 This category consisted of balancing pain and 
daily life and being resigned to one's condition.
 Balancing pain and daily life. This was defined as 
the act and mindset of achieving equilibrium between 
chronic pain management and level of functioning in life 
domains. Participants described that they endured severe 
pain and remained active, maintained social relationships 
by going to the hospital, and adjusted their routine 
according to the pain level: “…At any rate, I must move 
my body now, even if it hurts. In short, I have to move, 
eat to gain strength. Not being able to move because of 
pain is worse than experiencing pain.” (1-840)
 Participants referred directly to the experience of 
thinking positive and making the best of their situation: 
“I never fall ill; I am still healthy and do not even catch 
a cold.” (3-730-735)
 Being resigned to their condition. Participants had 
resigned themselves to their condition, pain, and medical 
treatment. In addition, they had reconciled chronic pain 
caused by self-accounts: “Earlier, I was in a lot more 
pain. Maybe my body is adjusting to pain” (6-1849-51) 
“Or rather made their cause, and I had cleaned it when 
the machines were moving, I got caught in (the roller in 
the factory), so, I caused my accident.” (6-1260)  
3・6　Regaining a Life”
 Regaining a life involved consciously leading a 
fulfilling life and being thankful for support and the 
fact that treatment reduced pain and led to improved 
functioning and QoL: “So, maybe, let's think positive! 
Until now, I couldn't go to my parents'  house, put too 
much effort into work, or meet people because of the 
pain.” (7-1661-1663)
4.　Discussion
 To our knowledge, this study was the first to 
qualitatively examine the experience of chronic opioid 
therapy in Asian outpatients with chronic non-cancer 
pain. Most studies to date have used quantitative 
methods to examine QoL issues surrounding chronic 
pain and opioid use. This study was unique in Japan in 
that it examined opioid therapy from the patients' 
perspective using a grounded theory approach. 
 Only three qualitative studies have examined life 
before and after opioid use for chronic non-cancer pain. 
Like our results, Vallerand and Nowak 26） identified 
that life before opioid pain control involved desperation, 
thoughts of suicide, willingness to endure humiliation, and 
inability to function (emotional, physical, role). However, 
patients experienced desperation and had thoughts of 
suicide even after opioid therapy when facing injustice 
or extreme chronic pain and catastrophizing. In a 
recent study 37）, patients with chronic pain who engaged in 
catastrophizing significantly increased their morphine 
consumption, resulting in an increased risk of overdose. It 
might be that people with chronic non-cancer pain do 
not find relief from traditional medical techniques 
including opioids, and that they must learn to live with 
it 24）. Healthcare professionals should offer patients 
alternative and complementary therapy (ACT) to help 
them find a compromise regarding their chronic pain, 
mental state, and daily life. In addition, healthcare 
professionals can help patients regain normalcy even if 
pain does not subside.
 This study illustrates the barriers individuals 
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encounter when undergoing long-term opioid therapy 
for treatment of chronic non-cancer pain in Japan. Like 
this study, Vallerand and Nowak 27） identified that patients 
receiving chronic opioid therapy cope with numerous 
barriers to maintaining their pain management regimen. 
These barriers are associated with family, friends, the 
healthcare system, and society at large. In addition, they 
showed that there is a gap in the understanding of 
chronic pain in society. In a study of health service 
facilities for the elderly requiring care in Japan 9）, nurses 
tended to have a misconception regarding how residents 
complained of pain and their pain sensitivity. Furthermore, 
organizational strategies for pain management were 
not reported by nurses and care workers. This may cause 
a gap in the understanding of pain because healthcare 
professionals lack pain management education for 
chronic non-cancer pain in Japan. In Nakamura et al.'s 
study 38）, the degree of satisfaction with treatment was 
low, and 66% of the patients had switched medical 
facilities. The reason cited for visiting new facilities or 
discontinuing treatment was the inefficacy of treatment. 
The first treating facility was an orthopedics in slightly 
more than 60% of all responders, while the share of 
orthopedics as the treating facility decreased to about 
50% after the first change of the treating facility. 
However, there was no marked change in the use of folk 
remedies (massage, acupuncture). Therefore, the degree 
of satisfaction with treatment at medical facilities was 
lower than that with folk remedies, suggesting that the 
initial treatment provided at medical facilities may not be 
adequate. To diminish or alleviate barriers and reduce 
stigma, ongoing education about chronic pain and non-
cancer opioid therapy are recommended for healthcare 
professionals. 
 In another study 39）, physical limitations were a 
major barrier for individuals living with chronic pain. 
Although inability to function leads to impairment 26）, 
being worn out from living with debilitating chronic 
pain extends beyond physical impairment. Participants 
experienced intense pain attacks and had debilitating 
chronic pain caused by daily life even though they were 
receiving opioid therapy. In addition, they experienced 
ambivalence about receiving opioid therapy. Participants 
had both positive and negative experiences with opioid 
therapy, including drugs with little response and 
unmanageable side effects. Awareness of the benefits 
and consequences of opioid therapy with chronic non-cancer 
pain will enable healthcare professionals to intervene 
appropriately and act as advocates for patients.
 Participants experienced a dilemma regarding 
medical treatments. Reliance on medical treatment made 
them apprehensive about dependence. It is, therefore, 
necessary to establish a relationship of trust with the 
patient before suggesting opioid therapy 23）. Nakamura 
et al. 38） showed that persons with chronic musculoskeletal 
pain in Japan often decided to discontinue treatment 
or seek no treatment for chronic pain persisting for 
three years or more, on grounds such as “I did not 
have sufficient time,” “I thought I could take care of it 
myself,” and “I thought treatment was unnecessary.” 
Therefore, in general, the Japanese may be wary of 
medication. There is no evidence of the efficacy or 
safety of methods for reducing prescribed opioid use in 
individuals with chronic pain 40）. Reduction of opioid use 
is clinically challenging and very difficult to achieve. 
Dose reductions were achieved among chronic opioid 
therapy patients at high risk for opioid-related adverse 
outcomes that were at least as large as among lower-risk 
patients 41）. Dose reductions and medication changes 
must be achieved through careful monitoring because 
of the risks of opioid side effects among older adults 42）. 
However, ACT such as yoga has been found beneficial 
in improving QoL or pain intensity of opioid users 43, 44）. 
An appealing aspect of ACT is the perception that it is 
natural and unlikely to cause harm. Therefore, ACT 
may be of benefit for Japanese people who prefer not to 
take medication. 
 These findings expand our understanding of 
Japanese patients who receive opioid treatment owing 
to chronic pain, with an emphasis on understanding 
their coping in daily life. Participants receiving opioid 
therapy attempted to improve their condition, and coped 
by balancing pain with daily life activities and accepting 
their condition. All this was done in an attempt to regain 
their life, as in a previous study 26）. However, patients 
were apprehensive about medical, especially opioid, 
dependence. While they had attempted treatments to 
improve their condition, they faced a dilemma regarding 
medical treatment, were ambivalent about receiving 
opioid therapy, and resigned themselves to their pain. 
Healthcare professionals should encourage people living 
with non-cancer pain to accept their pain and lead a 
fulfilling life. 
 High doses and prolonged use of opioid therapy have 
been known to cause serious problems such as intestinal, 
sexual, cognitive, and immune dysfunction; abuse and 
dependence; analgesic tolerance; and pain sensitivity 20, 45）. 
In a recent population-based study 46）, addictive behaviors 
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were identified in 22.6% of long-term opioid users with 
chronic pain, compared with 11.5% of non-opioid users with 
chronic pain and 8.9% of individuals without chronic 
pain. There was a strong association between long-term 
opioid use and addictive behaviors. Opioid treatments 
have to be discontinued, or the dose reduced, if the 
patient experiences a significant improvement in the 
painful condition (such as improvement of ADLs and 
QoL) or a poor treatment outcome. It is important to 
caution the patient about opioid-related side effects and 
to halt treatment not only at the appearance of negative 
signs and deteriorating QoL but also if QoL improves. 
For this reason, at the outset, patients must undergo a 
comprehensive examination to determine the suitability 
of an opioid prescription. Moreover, we should explain 
to patients beforehand all the side effects and opioid 
abuse risks and help them understand that this is not 
a permanent treatment method. 
 Early clinical outcome data suggest  47, 48） that while 
pain and opioid use can be reduced in patients with 
chronic pain, patients who also receive ACT intervention 
have a larger decrease in daily opioid dose while reporting 
less pain interference and lower depression scores. In 
addition, an innovative model to address aspects of pain 
management and opioid utilization during preoperative 
evaluation, acute surgical hospitalization, and postoperative 
follow-up for chronic opioid users has been reported 49）. 
This program involves multidisciplinary teams that 
include acute and chronic pain specialists, psychiatrists, 
integrative medicine specialists, and physical medicine 
and rehabilitation services. ACT and multidisciplinary 
programs such as this have the potential to both improve 
perioperative pain control and prevent escalation of 
opioid use among chronic opioid users. 
5.　Limitations 
 All participants resided in Hokkaido, Japan; 
therefore, the findings cannot be generalized to the 
greater population of people living with chronic non-
cancer pain. In addition, our results do not include 
clinical observations that illustrate how physicians 
communicated the risk of opioids to their patients and 
how patients responded to these discussions.
6.　Conclusion
 Participants were worn out from living with 
debilitating chronic pain, faced multiple barriers 
related to living with chronic pain, and faced injustice 
or extreme chronic pain and catastrophizing. While they 
had attempted treatments to improve their condition, 
they faced a dilemma regarding medical treatment, 
were ambivalent about receiving opioid therapy, and 
compromised to accept pain and regain normalcy.
 Patients with chronic pain may be willing to 
attempt novel treatments; therefore, ensuring that 
patients understand opioid therapy is critical. For 
example, healthcare professionals can propose weight-
loss drug use or change medicines to regulate patients' 
pain. Specifically, it is key to monitor opioid therapy, 
including dosage and medication, with elderly adults 
since side effects may increase with age and worsening 
conditions.
 In sum, these findings expand our understanding 
regarding the QoL of Japanese patients with chronic 
pain and how they cope in daily life. Healthcare 
professionals should encourage people living with non-
cancer pain to accept their pain and lead a fulfilling 
life. First, it is important that healthcare professionals 
understand, and be receptive to learning about, the social 
injustices that patients with chronic pain experience. 
Second, during opioid therapy, it is necessary that 
healthcare professionals understand the feelings of 
patients who are ambivalent about receiving this 
treatment. If the extent of the patient's pain has reduced, 
healthcare professionals should suggest reducing the 
opioid dose or changing medication. Third, patients 
with chronic pain may fear recurrence of pain with a 
reduced dose. Therefore, if a patient's pain increases after 
their opioid dose is reduced, healthcare professionals 
should provide pain relief to continue the treatment 
plan. Finally, if a patient's pain is refractory to opioids, 
reduction of the prescribed opioid dose may be the 
desired and shared goal of both patient and clinician. 
At the very least, patients with chronic pain must cope 
by balancing pain and daily activities and resigning 
themselves to their condition to regain normalcy. 
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非がん性慢性痛患者が日本でオピオイド治療を受けながら
生きる体験：グランデッドセオリー研究
進 藤 ゆ か り 1），青 柳 道 子 2），岩 崎 創 史 3），山 蔭 道 明 3）
1） 日本医療大学保健医療学部
2） 北海道大学大学院保健科学研究院
3） 札幌医科大学麻酔科学講座
　本研究の目的は，日本で非がん性慢性痛に対するオピ
オイド療法を受けている患者の生きてきた生活体験を
明らかにすることである．
　研究対象者は，ペインクリニックで治療を受けてい
た非がん性慢性痛患者 34 人であり，慢性痛を抱えて
オピオイド治療を受けながら生きていく日常の生活体
験や思いについて，率直に語ってもらった．データは
半構造化インタビューを用いて収集され，グラウン
デッド・セオリー・アプローチで分析した．結果，非
がん性慢性痛に対してオピオイド治療を受けながら生
きてきた体験として，6 カテゴリが抽出された．オピ
オイド治療受けている非がん性慢性痛患者は，彼ら独自
の方法で痛みにより良く対処するために，「状況打開
を目指した試み」を行いながら，「慢性的な痛みと暮
らしながら妥協していく」ことによって，彼らの通常
の生活を再開することへ影響を与え，「活きることへ
の再起」に向かっていた．一方で，「慢性痛と生きる
ことへの社会の壁」，「不条理で耐え難い痛みによって
心の闇を抱える」ことが，痛みに対する対処行動に悪
影響をきたし，「医療に対する両価性な気持ち」が，
良くも悪くも彼らに影響を与えていた．これらの知見
は，オピオイド治療を受ける非がん性慢性痛患者がど
のように日常生活に対処しているのか，その理解を医
療従事者に広く深めることができる．
